Myogen
Acquired
- Headquarters
- Westminster, Colorado
- Employees
- 51–200
- Founded
- 2001
- Business Model
- B2B
- Website
- myogen.com
- Last Round
- Series DAug 2003
About
Myogen was a privately held biopharmaceutical company headquartered in Westminster, Colorado, dedicated to discovering, developing, and commercializing drugs for heart failure and related cardiovascular conditions, including pulmonary arterial hypertension. Founded as a spin-off from the University of Colorado, Myogen advanced two key compounds before being acquired by Gilead Sciences in 2006 for $2.5 billion.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account